William Kevin相关文献与解析，生知库 | 链接生命科学的每一步

Perez Kerkvliet, Carlos Jesus; Leong, Joon Yau; Thompson, Rasheed A M; Zarrabi, Kevin Kayvan; Kelly, William Kevin; Lallas, Costas; Gomella, Leonard; Shah, Mihir

肿瘤

前列腺癌

肿瘤免疫

发表日期：2025

文献求助收藏

Unplanned hospitalization among advanced prostate cancer patients by diabetes status: a population-based study

晚期前列腺癌患者非计划住院情况与糖尿病状况的关系：一项基于人群的研究

期刊:JNCI Cancer Spectrum

影响因子:4.1

doi:10.1093/jncics/pkaf070

Shaver, Amy L; Gandhi, Krupa; Keith, Scott W; Nikita, Nikita; Yang, Christopher C; Kim, Felix J; Yang, Hushan; Kelly, William Kevin; Freedland, Stephen J; Lu-Yao, Grace

TARGET: A Randomized, Noninferiority Trial of a Pretest, Patient-Driven Genetic Education Webtool Versus Genetic Counseling for Prostate Cancer Germline Testing

TARGET：一项随机、非劣效性试验，比较预检测、患者主导的遗传教育网络工具与遗传咨询在前列腺癌胚系检测中的应用。

期刊:Jco Precision Oncology

影响因子:5.6

doi:10.1200/PO.23.00552

Loeb, Stacy; Keith, Scott W; Cheng, Heather H; Leader, Amy E; Gross, Laura; Sanchez Nolasco, Tatiana; Byrne, Nataliya; Hartman, Rebecca; Brown, Lauren H; Pieczonka, Christopher Michael; Gomella, Leonard G; Kelly, William Kevin; Lallas, Costas D; Handley, Nathan; Mille, Patrick Johnston; Mark, James Ryan; Brown, Gordon Andrew; Chopra, Sameer; McClellan, Alexandra; Wise, David R; Hollifield, Lucas; Giri, Veda N

Contribution of plasma levels of VEGF-A and angiopoietin-2 in addition to a genetic variant in KCNAB1 to predict the risk of bevacizumab-induced hypertension

血浆中 VEGF-A 和血管生成素-2 水平以及 KCNAB1 基因变异对预测贝伐珠单抗诱发高血压风险的贡献

期刊:Pharmacogenomics Journal

影响因子:2.9

doi:10.1038/s41397-024-00342-1

Quintanilha, Julia C F; Kelly, William Kevin; Innocenti, Federico

External Validation of a Prognostic Model of Overall Survival in Men With Chemotherapy-Naïve Metastatic Castration-Resistant Prostate Cancer

对未经化疗的转移性去势抵抗性前列腺癌患者总生存期预后模型进行外部验证

期刊:Journal of Clinical Oncology

影响因子:41.9

doi:10.1200/JCO.22.02661

Halabi, Susan; Yang, Qian; Roy, Akash; Luo, Bin; Araujo, John C; Logothetis, Christopher; Sternberg, Cora N; Armstrong, Andrew J; Carducci, Michael A; Chi, Kim N; de Bono, Johann S; Petrylak, Daniel P; Fizazi, Karim; Higano, Celestia S; Morris, Michael J; Rathkopf, Dana E; Saad, Fred; Ryan, Charles J; Small, Eric J; Kelly, William Kevin

Master Transcription Factor Reprogramming Unleashes Selective Translation Promoting Castration Resistance and Immune Evasion in Lethal Prostate Cancer

主转录因子重编程释放选择性翻译，促进致命前列腺癌的去势抵抗和免疫逃避

期刊:Cancer Discovery

影响因子:29.7

doi:10.1158/2159-8290.CD-23-0306

Sandra Santasusagna #, Shijia Zhu #, Vijayakumar Jawalagatti #, Marc Carceles-Cordon, Adam Ertel, Saioa Garcia-Longarte, Won-Min Song, Naoto Fujiwara, Peiyao Li, Isabel Mendizabal, Daniel P Petrylak, William Kevin Kelly, E Premkumar Reddy, Liguo Wang, Matthew J Schiewer, Amaia Lujambio, Jeffrey Karn

信号转导

肿瘤

前列腺癌

Translational Control

发表日期：2023

文献求助收藏

Bispecific PSMA antibodies and CAR-T in metastatic castration-resistant prostate cancer

双特异性PSMA抗体和CAR-T疗法治疗转移性去势抵抗性前列腺癌

期刊:Therapeutic Advances in Urology

影响因子:3.5

doi:10.1177/17562872231182219

Zarrabi, Kevin K; Narayan, Vivek; Mille, Patrick J; Zibelman, Matthew R; Miron, Benjamin; Bashir, Babar; Kelly, William Kevin

Plasma levels of angiopoietin-2, VEGF-A, and VCAM-1 as markers of bevacizumab-induced hypertension: CALGB 80303 and 90401 (Alliance)

血浆中血管生成素-2、VEGF-A 和 VCAM-1 的水平作为贝伐珠单抗诱发高血压的标志物：CALGB 80303 和 90401（联盟）

期刊:Angiogenesis

影响因子:9.2

doi:10.1007/s10456-021-09799-1

Quintanilha, Julia C F; Liu, Yingmiao; Etheridge, Amy S; Yazdani, Akram; Kindler, Hedy L; Kelly, William Kevin; Nixon, Andrew B; Innocenti, Federico

Correction: Bevacizumab-induced hypertension and proteinuria: a genome-wide study of more than 1000 patients

更正：贝伐珠单抗诱发的高血压和蛋白尿：一项纳入1000多名患者的全基因组研究

期刊:British Journal of Cancer

影响因子:6.8

doi:10.1038/s41416-021-01617-1

Quintanilha, Julia C F; Wang, Jin; Sibley, Alexander B; Jiang, Chen; Etheridge, Amy S; Shen, Fei; Jiang, Guanglong; Mulkey, Flora; Patel, Jai N; Hertz, Daniel L; Dees, Elizabeth Claire; McLeod, Howard L; Bertagnolli, Monica; Rugo, Hope; Kindler, Hedy L; Kelly, William Kevin; Ratain, Mark J; Kroetz, Deanna L; Owzar, Kouros; Schneider, Bryan P; Lin, Danyu; Innocenti, Federico

Bevacizumab-induced hypertension and proteinuria: a genome-wide study of more than 1000 patients

贝伐珠单抗诱发的高血压和蛋白尿：一项纳入1000多名患者的全基因组研究

期刊:British Journal of Cancer

影响因子:6.8

doi:10.1038/s41416-021-01557-w

Treatment Intensification Prior to Radical Prostatectomy for Clinically Localized Prostate Cancer

临床局限性前列腺癌根治性前列腺切除术前的强化治疗

Unplanned hospitalization among advanced prostate cancer patients by diabetes status: a population-based study

晚期前列腺癌患者非计划住院情况与糖尿病状况的关系：一项基于人群的研究

TARGET: A Randomized, Noninferiority Trial of a Pretest, Patient-Driven Genetic Education Webtool Versus Genetic Counseling for Prostate Cancer Germline Testing

TARGET：一项随机、非劣效性试验，比较预检测、患者主导的遗传教育网络工具与遗传咨询在前列腺癌胚系检测中的应用。

Contribution of plasma levels of VEGF-A and angiopoietin-2 in addition to a genetic variant in KCNAB1 to predict the risk of bevacizumab-induced hypertension

血浆中 VEGF-A 和血管生成素-2 水平以及 KCNAB1 基因变异对预测贝伐珠单抗诱发高血压风险的贡献

External Validation of a Prognostic Model of Overall Survival in Men With Chemotherapy-Naïve Metastatic Castration-Resistant Prostate Cancer

对未经化疗的转移性去势抵抗性前列腺癌患者总生存期预后模型进行外部验证

Master Transcription Factor Reprogramming Unleashes Selective Translation Promoting Castration Resistance and Immune Evasion in Lethal Prostate Cancer

主转录因子重编程释放选择性翻译，促进致命前列腺癌的去势抵抗和免疫逃避

Bispecific PSMA antibodies and CAR-T in metastatic castration-resistant prostate cancer

双特异性PSMA抗体和CAR-T疗法治疗转移性去势抵抗性前列腺癌

Plasma levels of angiopoietin-2, VEGF-A, and VCAM-1 as markers of bevacizumab-induced hypertension: CALGB 80303 and 90401 (Alliance)

血浆中血管生成素-2、VEGF-A 和 VCAM-1 的水平作为贝伐珠单抗诱发高血压的标志物：CALGB 80303 和 90401（联盟）

Correction: Bevacizumab-induced hypertension and proteinuria: a genome-wide study of more than 1000 patients

更正：贝伐珠单抗诱发的高血压和蛋白尿：一项纳入1000多名患者的全基因组研究

Bevacizumab-induced hypertension and proteinuria: a genome-wide study of more than 1000 patients

贝伐珠单抗诱发的高血压和蛋白尿：一项纳入1000多名患者的全基因组研究